The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
Open accessAbstract
BACKGROUND: A new autoinflammatory syndrome related to somatic mutations of UBA1 was recently described and called VEXAS syndrome ('Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome'). OBJECTIVES: To describe clinical characteristics, laboratory findings and outcomes of VEXAS syndrome. METHODS: One hundred and sixteen patients with VEXAS syndrome were referred to a French multicentre registry between November 2020 and May 2021. The frequency and median of parameters and vital status, from diagnosis to the end of the follow-up, were recorded. RESULTS: The main clinical features of VEXAS syndrome were found to be skin lesions (83%), noninfectious fever (64%), weight loss (62%), lung involvement (50%), ocular symptoms (39%), relapsing chondritis (36%), venous thrombosis (35%), lymph nodes (34%) and arthralgia (27%). Haematological disease was present in 58 cases (50%): myelodysplastic syndrome (MDS; n = 58) and monoclonal gammopathy of unknown significance (n = 12; all patients with MGUS also have a MDS). UBA1 mutations included p.M41T (45%), p.M41V (30%), p.M41L (18%) and splice mutations (7%). After a median follow-up of 3 years, 18 patients died (15·5%; nine of infection and three due to MDS progression). Unsupervised analysis identified three clusters: cluster 1 (47%; mild-to-moderate disease); cluster 2 (16%; underlying MDS and higher mortality rates); and cluster 3 (37%; constitutional manifestations, higher C-reactive protein levels and less frequent chondritis). The 5-year probability of survival was 84·2% in cluster 1, 50·5% in cluster 2 and 89·6% in cluster 3. The UBA1 p.Met41Leu mutation was associated with a better prognosis. CONCLUSIONS: VEXAS syndrome has a large spectrum of organ manifestations and shows different clinical and prognostic profiles. It also raises a potential impact of the identified UBA1 mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FactoMineR : An R Package for Multivariate Analysis
Lê, S., Josse, J., & Husson, F. (2008) · Journal of Statistical Software · doi:10.18637/jss.v025.i01 · Cited by 11,603
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
Beck, D. B., Ferrada, M. A., Sikora, K. A., Ombrello, A. K., Collins, J. C., Pei, W., Balanda, N., Ross, D. L., Ospina Cardona, D., Wu, Z., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026834 · Cited by 1,206
Therapeutic options in VEXAS syndrome: insights from a retrospective series
Bourbon, E., Heiblig, M., Gerfaud Valentin, M., Barba, T., Durel, C.-A., Lega, J. C., Barraco, F., Sève, P., Jamilloux, Y., & Sujobert, P. (2021) · Blood · doi:10.1182/blood.2020010177 · Cited by 280
Self-citationvan der Made, C. I., Potjewijd, J., Hoogstins, A., Willems, H. P. J., Kwakernaak, A. J., de Sevaux, R. G. L., van Daele, P. L. A., Simons, A., Heijstek, M., Beck, D. B., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.014 · Cited by 215
Autoimmune manifestations associated with myelodysplastic syndromes
Grignano, É., Jachiet, V., Fenaux, P., Adès, L., Fain, O., & MEKINIAN, A. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3472-9 · Cited by 105
Self-citationHuque, M. H., Moreno‐Betancur, M., Quartagno, M., Simpson, J. A., Carlin, J. B., & Lee, K. J. (2020) · Biometrical Journal · doi:10.1002/bimj.201900051 · Cited by 61
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
Huang, H., Zhang, W., Cai, W., Liu, J., Wang, H., Qin, T., Xu, Z., Li, B., Qu, S., Pan, L., et al. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00217-2 · Cited by 60
Magnol, M., Couvaras, L., Degboé, Y., Delabesse, É., Livideanu, C. B., Ruyssen‐Witrand, A., & Constantin, A. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab211 · Cited by 59
VEXAS syndrome: still expanding the clinical phenotype
Oganesyan, A., Jachiet, V., Chasset, F., Hirsch, P., Hage-Sleiman, M., Fabiani, B., Duriez, P., Georgin‐Lavialle, S., Delhommeau, F., Hakobyan, Y. K., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab225 · Cited by 56
Self-citationSevere Joint Involvement in VEXAS Syndrome: A Case Report
Lacombe, V., Kosmider, O., Prévost, M., et al. (2021) · Annals of Internal Medicine · doi:10.7326/l21-0023 · Cited by 34
Self-citation
Cited by
Chabrun, F., Lacombe, V., Dieu, X., Geneviève, F., & Urbanski, G. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1283 · Cited by 13
Self-citation
Metadata
- Authors
- Georgin‐Lavialle, S., Terrier, B., Guedon, A. F., Heiblig, M., Comont, T., Lazaro, E., Lacombe, V., Terriou, L., Ardois, S., Bouaziz, J. ‐., Mathian, A., Le Guenno, G., Aouba, A., Outh, R., Meyer, A., Roux‐Sauvat, M., Ebbo, M., Zhao, L. P., Bigot, A., Jamilloux, Y., Guillotin, V., Flamarion, E., Henneton, P., Vial, G., Jachiet, V., Rossignol, J., Vinzio, S., Weitten, T., Vinit, J., Deligny, C., Humbert, S., Samson, M., Magy‐Bertrand, N., Moulinet, T., Bourguiba, R., Hanslik, T., Bachmeyer, C., Sebert, M., Kostine, M., Bienvenu, B., Biscay, P., Liozon, E., Sailler, L., Chasset, F., Audemard‐Verger, A., Duroyon, E., Sarrabay, G., Borlot, F., Dieval, C., Cluzeau, T., Marianetti, P., Lobbes, H., Boursier, G., Gerfaud‐Valentin, M., Jeannel, J., Servettaz, A., Audia, S., Larue, M., Henriot, B., Faucher, B., Graveleau, J., de Sainte Marie, B., Galland, J., Bouillet, L., Arnaud, C., Ades, L., Carrat, F., Hirsch, P., Fenaux, P., Fain, O., Sujobert, P., Kosmider, O., Mekinian, A., French VEXAS group, & GFEV, G.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-28
- Volume
- 186
- Issue
- 3
- Pages
- 564-574
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W3206162992
- Cited by
- 427
- References
- 10
- FWCI
- 19.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*. https://app.cochat.ai/papers/10.1111/bjd.20805
- The paper
- Georgin‐Lavialle, S., Terrier, B., Guedon, A. F., Heiblig, M., Comont, T., Lazaro, E., Lacombe, V., Terriou, L., Ardois, S., Bouaziz, J. ‐., Mathian, A., Le Guenno, G., Aouba, A., Outh, R., Meyer, A., Roux‐Sauvat, M., Ebbo, M., Zhao, L. P., Bigot, A., . . . GFEV, G. (2022). Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*. British Journal of Dermatology. https://doi.org/10.1111/bjd.20805
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.